U.S. Packaged Salads Market Size, Share & Trends Analysis Report By Product (Vegetarian, Non-vegetarian), By Processing, By Type, By Category, By Distribution Channel, By State, And Segment Forecasts, 2024 - 2030

U.S. Packaged Salads Market Size, Share & Trends Analysis Report By Product (Vegetarian, Non-vegetarian), By Processing, By Type, By Category, By Distribution Channel, By State, And Segment Forecasts, 2024 - 2030


U.S. Packaged Salads Market Growth & Trends

The U.S. packaged salads market size is expected to reach USD 8.41 billion by 2030, growing at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is driven by several key factors, with health and convenience at the forefront. Increasing awareness about the importance of a balanced diet and the benefits of consuming fresh vegetables is encouraging more consumers to opt for ready-to-eat salad options. Packaged salads offer a quick and easy way to incorporate greens into daily meals, catering to the busy lifestyles of many Americans who may not have the time to prepare salads from scratch. This convenience factor is particularly appealing to working professionals, busy parents, and health-conscious individuals seeking nutritious meal solutions that require minimal preparation.

Additionally, the trend of healthier eating is supported by a growing body of research highlighting the positive impact of plant-based diets on overall health and well-being. This has led to an increased demand for fresh produce, including salads, as part of a regular diet. The packaged salad market has responded by offering a variety of options, including organic and non-GMO products, which appeal to consumers who are mindful of the quality and source of their food. The emphasis on clean eating and natural ingredients further drives the market, as shoppers look for products that align with their health goals and ethical values.

Innovation in product offerings is also a significant driver. Companies are continually developing new salad combinations, dressings, and packaging solutions to enhance the consumer experience. Pre-washed and pre-cut salads, along with single-serve options and customizable salad kits, cater to diverse tastes and preferences, making it easier for consumers to enjoy a fresh and varied diet. These innovations not only improve convenience but also reduce food waste, as consumers can purchase exactly what they need without worrying about unused produce spoiling.

In July 2023, Fresh Express unveiled the latest addition to its lineup-the French Blue Cheese salad kit. The brand also introduced three new options in its popular range of chopped salad kits: Smokehouse, French Bistro, and Twisted Caesar Enchilada. These fresh offerings expand its extensive selection to over 100 varieties of nutritious salad kits and blends.

U.S. Packaged Salads Market Report Highlights
  • Based on product, the vegetarian packaged salads segment accounted for a dominant revenue share of over 66% in 2023. Players are increasingly introducing and promoting vegetarian and vegan-friendly salad options, catering to the preferences of this growing consumer base. These salads often feature a variety of plant-based proteins, unique flavor profiles, and organic ingredients to appeal to health-conscious and environmentally aware consumers.
  • Based on processing, the organic packaged salad segment is projected to grow at a CAGR of 8.8% from 2024 to 2030. With the rising awareness about the potential health benefits of organic products rises more consumers are seeking out these options to avoid pesticides and genetically modified organisms (GMOs). Additionally, the perception that organic farming practices are better for the environment, coupled with the trend of clean eating and transparency in food sourcing, has fueled this demand. Enhanced availability and improved marketing of organic packaged salads also play a role, making these products more accessible and appealing to a broader range of health-conscious and eco-conscious consumers.
  • Based on type, the packaged greens market segment accounted for a revenue share of over 63% in 2023. Packaging innovations in the industry, such as resealable bags and environmentally friendly packaging, enhance the appeal of packaged greens. These features contribute to the preservation of freshness, reduce food waste, and align with the growing awareness of sustainability among consumers.
  • Based on category, the in-store/ private label market segment is projected to grow at a CAGR of 9.6% from 2024 to 2030. Consumer trust in private-label products is on the rise. As retailers invest in quality, transparency, and clear branding for their in-store salad options, consumers are more willing to try and trust these private label products. The perception of these salads as reliable, cost-effective alternatives to national brands is contributing to their growing popularity
  • The sales of U.S. packaged salads through offline distribution channels accounted for a revenue share of around 80% in 2023. The sales of packaged salads through offline distribution channels are driven primarily by consumers' increasing demand for convenient, healthy meal options. This trend is bolstered by the growing health consciousness.
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Cancer Type
1.2.3. Provider
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing incidence of cancers
3.2.1.2. Technology advancement
3.2.1.3. Rising medical tourism
3.2.1.4. Growing government investment in cancer treatment facility
3.2.2. Market Restraint Analysis
3.2.2.1. High initial investment cost to setup cancer treatment facility
3.2.2.2. Stringent regulations for cancer treatment facility setup
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Cancer Treatment Facilities Market: Treatment Estimates & Trend Analysis
4.1. Treatment Market Share, 2023 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Bone Marrow Transplantation
4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Chemotherapy
4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Radiation Therapy
4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Hormone Therapy
4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Immunotherapy
4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
4.9. Cancer Surgery
4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Cancer Treatment Facilities Market: Cancer Type Estimates & Trend Analysis
5.1. Cancer Type Market Share, 2023 & 2030
5.2. Cancer Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
5.4. Blood Cancer
5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Breast Cancer
5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Prostate Cancer
5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Gastrointestinal Cancer
5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Gynecologic Cancer
5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.9. Respiratory/Lung Cancer
5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.10. Other Cancer Types
5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Cancer Treatment Facilities Market: Provider Estimates & Trend Analysis
6.1. Provider Market Share, 2023 & 2030
6.2. Provider Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
6.4. Cancer Centers
6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Hospitals
6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Cancer Treatment Facilities Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.4. North America
7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. UK
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamic
7.5.8.2. Regulatory framework
7.5.8.3. Competitive insights
7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamic
7.5.9.2. Regulatory framework
7.5.9.3. Competitive insights
7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamic
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamic
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamic
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamic
7.6.7.2. Regulatory framework
7.6.7.3. Competitive insights
7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamic
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamic
7.8.3.2. Regulatory framework
7.8.3.3. Competitive insights
7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamic
7.8.4.2. Regulatory framework
7.8.4.3. Competitive insights
7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamic
7.8.5.2. Regulatory framework
7.8.5.3. Competitive insights
7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Compass Oncology
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Service benchmarking
8.5.1.4. Strategic initiatives
8.5.2. American Oncology Institute
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Service benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Service benchmarking
8.5.3.4. Strategic initiatives
8.5.4. HCA International Limited
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Service benchmarking
8.5.4.4. Strategic initiatives
8.5.5. The Royal Marsden
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Service benchmarking
8.5.5.4. Strategic initiatives
8.5.6. National Cancer Instituteat the National Institutes of Health
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Service benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Apollo Hospitals Enterprise Ltd.
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Service benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Kokilaben Dhirubhai Ambani Hospital
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Service benchmarking
8.5.8.4. Strategic initiatives
8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
8.5.9.1. Overview
8.5.9.2. Financial performance
8.5.9.3. Service benchmarking
8.5.9.4. Strategic initiatives
8.5.10. The Johns Hopkins Hospital
8.5.10.1. Overview
8.5.10.2. Financial performance
8.5.10.3. Service benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Tata Memorial Centre.
8.5.11.1. Overview
8.5.11.2. Financial performance
8.5.11.3. Service benchmarking
8.5.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings